Events

Recall of Novocastra Terminal Deoxynucleotidyl Transferase RTU-TdT-339 reagent

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by A.MENARINI DIAGNOSTICS.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2012-12-07
  • Event Country
    France
  • Event Source
    ANSM
  • Event Source URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/reactif-novocastra-terminal-deoxynucleotidyl-transferase-rtu-tdt-339-leica-retrait-de-lots
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    A.MENARINI DIAGNOSTICS informed the users of the Novocastra Terminal Deoxynucleotidyl Transferase RTU-TdT-339 reagent of batch removal. The users concerned, in France, received the attached mail (07/12/2012) (1624 KB). This information is addressed to the directors of health establishments, medical biologists and local correspondents of reactovigilance for diffusion to the concerned services.

Device

Novocastra Terminal Deoxynucleotidyl Transferase RTU-TdT-339 reagent

Manufacturer

A.MENARINI DIAGNOSTICS